Earnings Call Summary | MEDIPHARM LABS CORP(MEDIF.US) Q4 2023 Earnings Conference
The following is a summary of the MediPharm Labs Corp. (MEDIF) Q4 2023 Earnings Call Transcript:Financial Performance:MediPharm reported Q4 2023 revenue of $9.1 million, a 63% increase compared to the
MediPharm Labs Provides Conference Call Recording Details
TORONTO, March 27, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-ba
MediPharm Labs Corp. Brief: Q4 Revenue $9.131 Million; Says Annual Revenue and Adjusted EBITDA Improve by 50%
06:33 AM EDT, 03/27/2024 (MT Newswires) -- MediPharm Labs Corp. Brief: Q4 Revenue $9.131 Million; Says Annual Revenue and Adjusted EBITDA Improve by 50%
MediPharm Labs Corp. Brief: Says "Historic Change Is a Significant Positive Step in Removing the Stigma Related to Medical Cannabis"
06:32 AM EDT, 03/25/2024 (MT Newswires) -- MediPharm Labs Corp. Brief: Says "Historic change is a significant positive step in removing the stigma related to medical cannabis"
MediPharm Labs Corp. Brief: Providing Update on German Cannabis Legalization
06:31 AM EDT, 03/25/2024 (MT Newswires) -- MediPharm Labs Corp. Brief: Providing Update on German Cannabis Legalization
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results
Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil
MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) has received a GMP certification for its Barrie, Ontario facility from ANVISA, the governing body of Brazil's pharmaceutical industry.This is M
MediPharm Labs Corp. Brief: Says Achieved Pharmaceutical GMP Certification With Brazilian Health Authority
06:31 AM EST, 02/07/2024 (MT Newswires) -- MediPharm Labs Corp. Brief: Says Achieved Pharmaceutical GMP Certification with Brazilian Health Authority
Stocks in Play: MediPharm Labs Corp.
MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report
MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of arou
MediPharm Labs Reports Q3 Results
MediPharm Labs Corp. Updated On $9 Million Settlement Agreement; All Tilray Shares Sold and Converted to Cash
MediPharm Labs Corp. (TSX: LABS), a company specialized in precision-based cannabinoids, announced Wednesday it has now received $7.27 Million in gross cash proceeds from the settlement agreement anno
New Cannabis Products Energize Global Health & Wellness Market, Including Australia
In the ever-evolving world of cannabis products, innovation is the name of the game for those in search of health and wellness solutions. From organic CBD sleep gummies to premium cannabis extracts an
MediPharm to Receive Outstanding Settlement of $9M From Tilray
MediPharm Labs Corp. Brief: Says Settled an Outstanding Claim for $9 Million
07:10 AM EDT, 10/02/2023 (MT Newswires) -- MediPharm Labs Corp. Brief: Says Settled an Outstanding Claim for $9 Million
New CBD & THC Cannabis Oils Now Shipping To Australia From Canada
MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced on Wednesday that Canadian-produced GMP Beacon Medical cannabis oil and inhalation cartridges have launched in the Australian medical
MediPharm Labs Launches New GMP Products to the Australian Medical Cannabis Market
The launch includes GMP strain-specific full spectrum cannabis oil and inhalation cartridge products to be distributed to patients under the MediPharm Labs Beacon Medical brand. As of July 2023, all Australian medical
MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next
MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) has executed a supplementary agreement to its asset purchase agreement with 1193269 B.C. Ltd., operating as Shelter Cannabis for the Shelter Ca
MediPharm Labs Improves Domestic Sales Gross Margin With Termination of Shelter Cannabis Brands Royalty Agreement
MediPharm Labs and Shelter Cannabis Brands have terminated their royalty agreement with a one-time cash payment.Agreement includes the elimination of ongoing royalty payments, for a one-time lump sum payment.TORONTO,
MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 Million
MediPharm Labs sold vacant land in Napanee, Ontario last utilized in 2021 for outdoor cannabis growing activities. The land was acquired by MediPharm as part of the VIVO Cannabis acquisition in April 2023.The net cash
No Data